Medical technology company Bay Labs has announced that its EchoMD AutoEF software product has secured US Food and Drug Administration (FDA) clearance.

The FDA awarded 510(k) clearance to the EchoMD AutoEF software for complete automated clip selection and calculation of left ventricular ejection fraction (EF).

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

EF is one of the most widely used measurements of cardiac function from echocardiograms and helps in taking various clinical decisions.

“The artificial intelligence-based EchoMD AutoEF software algorithm is trained on clip selection and EF calculation. The training included analysis of a dataset containing more than 4 million from 9,000 patients.”

The solution, by running algorithms, automatically assesses all the digital video clips of cardiac cycles from a patient’s echocardiography study and selects the best clips to calculate the EF.

Accordingly, it eliminates the time-consuming manual process of choosing views.

Bay Labs co-founder and CEO Charles Cadieu said: “At Bay Labs, our hope is that EchoMD AutoEF will assist cardiologists in their decision making and enhance the care they provide to their patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We look forward to continuing to develop unique deep learning technologies that enable expanded access to high-quality echocardiography image acquisition and interpretation, with the goal to improve disease management and patient outcomes through earlier detection and monitoring.”

The artificial intelligence-based EchoMD AutoEF software algorithm is trained on clip selection and EF calculation. The training included analysis of a dataset containing more than 4 million from 9,000 patients.

EchoMD AutoEF software is designed to enable swift integration with any form of DICOM PACS medical imaging environment.

The combination will allow the cardiologists to receive echocardiogram analysis seamlessly to facilitate diagnostic workflow.

Bay Labs expects that the introduction of EchoMD AutoEF will provide better medical services and care to cardiac patients.